| 000 | 01692 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516162656.0 | ||
| 264 | 0 | _c20140512 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1552-4604 | ||
| 024 | 7 |
_a10.1002/jcph.154 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGómez-Bravo, Miguel Angel | |
| 245 | 0 | 0 |
_aImpact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cNov 2013 |
||
| 300 |
_a1146-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 |
_aGraft Rejection _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 |
_aWhite People _xgenetics |
| 700 | 1 | _aSalcedo, Magdalena | |
| 700 | 1 | _aFondevila, Constantino | |
| 700 | 1 | _aSuarez, Francisco | |
| 700 | 1 | _aCastellote, José | |
| 700 | 1 | _aRufian, Sebastián | |
| 700 | 1 | _aPons, José Antonio | |
| 700 | 1 | _aAlamo, José María | |
| 700 | 1 | _aMillán, Olga | |
| 700 | 1 | _aBrunet, Mercè | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 53 _gno. 11 _gp. 1146-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcph.154 _zAvailable from publisher's website |
| 999 |
_c22961747 _d22961747 |
||